Alanine glutamine dipeptide C₈H₁₅N₃O₄
Also known as: Alanine glutamine

Therapeutic indications

Alanine glutamine dipeptide is indicated for:

Hypercatabolic states, hypermetabolic states

Population group: both men and women, only adults (18 years old or older)

Alanyl glutamine is indicated as part of a clinical nutrition regimen in patients in hypercatabolic and/or hypermetabolic states. It should be given together with parenteral or enteral nutrition or a combination of both.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Alanine glutamine dipeptide is contraindicated in the following cases:

Severe renal insufficiency (creatinine clearance <25 ml/minute)

at least one of

Renal failure stage 5: Kidney failure (GFR <15 mL/min/1.73 m2 or dialysis)

Severe hepatic insufficiency

Hepatic failure stage IV

Severe metabolic acidosis

Metabolic acidosis (disorder)

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2015: DIPEPTIVEN Concentrate for solution for infusion
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈